These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

194 related items for PubMed ID: 23647979

  • 1. Periprocedural dabigatran in atrial fibrillation ablation: a new kid on the block.
    Pelargonio G, Perna F.
    J Cardiovasc Electrophysiol; 2013 Aug; 24(8):866-8. PubMed ID: 23647979
    [No Abstract] [Full Text] [Related]

  • 2. Catheter ablation of atrial fibrillation: the need for studies to assess the efficacy and safety of novel anticoagulants.
    Naccarelli GV, Gonzalez MD.
    J Interv Card Electrophysiol; 2013 Jan; 36(1):3-4. PubMed ID: 23054126
    [No Abstract] [Full Text] [Related]

  • 3. Dabigatran versus warfarin therapy for uninterrupted oral anticoagulation during atrial fibrillation ablation.
    Maddox W, Kay GN, Yamada T, Osorio J, Doppalapudi H, Plumb VJ, Gunter A, McElderry HT.
    J Cardiovasc Electrophysiol; 2013 Aug; 24(8):861-5. PubMed ID: 23577951
    [Abstract] [Full Text] [Related]

  • 4. Continuous warfarin versus periprocedural dabigatran to reduce stroke and systemic embolism in patients undergoing catheter ablation for atrial fibrillation or left atrial flutter.
    Kaiser DW, Streur MM, Nagarakanti R, Whalen SP, Ellis CR.
    J Interv Card Electrophysiol; 2013 Sep; 37(3):241-7. PubMed ID: 23625091
    [Abstract] [Full Text] [Related]

  • 5. A comparison of bleeding complications post-ablation between warfarin and dabigatran.
    Snipelisky D, Kauffman C, Prussak K, Johns G, Venkatachalam K, Kusumoto F.
    J Interv Card Electrophysiol; 2012 Oct; 35(1):29-33. PubMed ID: 22869389
    [Abstract] [Full Text] [Related]

  • 6. Differences in intraprocedural ACTs with standardized heparin dosing during catheter ablation for atrial fibrillation in patients treated with dabigatran vs. patients on uninterrupted warfarin.
    Konduru SV, Cheema AA, Jones P, Li Y, Ramza B, Wimmer AP.
    J Interv Card Electrophysiol; 2012 Dec; 35(3):277-84; discussion 284. PubMed ID: 23015216
    [Abstract] [Full Text] [Related]

  • 7. Efficacy and safety of periprocedural dabigatran in patients undergoing catheter ablation of atrial fibrillation.
    Kaseno K, Naito S, Nakamura K, Sakamoto T, Sasaki T, Tsukada N, Hayano M, Nishiuchi S, Fuke E, Miki Y, Nakamura K, Yamashita E, Kumagai K, Oshima S, Tada H.
    Circ J; 2012 Dec; 76(10):2337-42. PubMed ID: 22785434
    [Abstract] [Full Text] [Related]

  • 8. Periprocedural dabigatran anticoagulation for atrial fibrillation ablation: do we have enough information to make a rational decision.
    Noheria A, Asirvatham SJ.
    J Interv Card Electrophysiol; 2013 Sep; 37(3):209-11. PubMed ID: 23892446
    [No Abstract] [Full Text] [Related]

  • 9. Safety of novel oral anticoagulants compared with uninterrupted warfarin for catheter ablation of atrial fibrillation.
    Armbruster HL, Lindsley JP, Moranville MP, Habibi M, Khurram IM, Spragg DD, Berger RD, Calkins H, Marine JE.
    Ann Pharmacother; 2015 Mar; 49(3):278-84. PubMed ID: 25515868
    [Abstract] [Full Text] [Related]

  • 10. Feasibility and safety of uninterrupted dabigatran therapy in patients undergoing ablation for atrial fibrillation.
    Nagao T, Inden Y, Shimano M, Fujita M, Yanagisawa S, Kato H, Ishikawa S, Miyoshi A, Okumura S, Ohguchi S, Yamamoto T, Yoshida N, Hirai M, Murohara T.
    Intern Med; 2015 Mar; 54(10):1167-73. PubMed ID: 25986252
    [Abstract] [Full Text] [Related]

  • 11. Dabigatran for periprocedural anticoagulation following radiofrequency ablation for atrial fibrillation: a meta-analysis of observational studies.
    Steinberg BA, Hasselblad V, Atwater BD, Bahnson TD, Washam JB, Alexander JH, Daubert JP, Piccini JP.
    J Interv Card Electrophysiol; 2013 Sep; 37(3):213-21. PubMed ID: 23881249
    [Abstract] [Full Text] [Related]

  • 12. Dabigatran versus warfarin anticoagulation before and after catheter ablation for the treatment of atrial fibrillation.
    Haines DE, Mead-Salley M, Salazar M, Marchlinski FE, Zado E, Calkins H, Yarmohammadi H, Nademanee K, Amnueypol M, Skanes AC, Saklani P.
    J Interv Card Electrophysiol; 2013 Sep; 37(3):233-9. PubMed ID: 23740224
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Response to Letter by May et al regarding article, "Use of dabigatran for periprocedural anticoagulation in patients undergoing catheter ablation for atrial fibrillation" by Bassiouny et al.
    Bassiouny M, Saliba W, Rickard J, Shao M, Sey A, Diab M, Martin DO, Hussein A, Khoury M, Abi-Saleh B, Alam S, Sengupta J, Borek PP, Baranowski B, Niebauer M, Callahan T, Varma N, Chung M, Tchou PJ, Kanj M, Dresing T, Lindsay BD, Wazni O.
    Circ Arrhythm Electrophysiol; 2013 Aug; 6(4):e66. PubMed ID: 23962867
    [No Abstract] [Full Text] [Related]

  • 16. A randomized controlled trial of dabigatran versus warfarin for periablation anticoagulation in patients undergoing ablation of atrial fibrillation.
    Nin T, Sairaku A, Yoshida Y, Kamiya H, Tatematsu Y, Nanasato M, Inden Y, Hirayama H, Murohara T.
    Pacing Clin Electrophysiol; 2013 Feb; 36(2):172-9. PubMed ID: 23121681
    [Abstract] [Full Text] [Related]

  • 17. Balancing the benefits and risks of 2 doses of dabigatran compared with warfarin in atrial fibrillation.
    Eikelboom JW, Connolly SJ, Hart RG, Wallentin L, Reilly P, Oldgren J, Yang S, Yusuf S.
    J Am Coll Cardiol; 2013 Sep 03; 62(10):900-8. PubMed ID: 23770182
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Can dabigatran be an alternative periprocedural anticoagulation for atrial fibrillation ablation?
    Takahashi N.
    Circ J; 2012 Sep 03; 76(10):2327-8. PubMed ID: 22785435
    [No Abstract] [Full Text] [Related]

  • 20. Reversing dabigatran in life-threatening bleeding occurring during cardiac ablation with factor eight inhibitor bypassing activity.
    Dager WE, Gosselin RC, Roberts AJ.
    Crit Care Med; 2013 May 03; 41(5):e42-6. PubMed ID: 23474679
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.